Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May 29;8(7):390-8.
doi: 10.1038/nrrheum.2012.80.

Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis

Affiliations
Review

Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis

Paul I Mapp et al. Nat Rev Rheumatol. .

Abstract

During osteoarthritis (OA), angiogenesis is increased in the synovium, osteophytes and menisci and leads to ossification in osteophytes and the deep layers of articular cartilage. Angiogenic and antiangiogenic factors might both be upregulated in the osteoarthritic joint; however, vascular growth predominates, and the articular cartilage loses its resistance to vascularization. In addition, blood vessel growth is increased at--and disrupts--the osteochondral junction. Angiogenesis in this location is dependent on the creation of channels from subchondral bone spaces into noncalcified articular cartilage. Inflammation drives synovial angiogenesis through macrophage activation. Blood vessel and nerve growth are linked by common pathways that involve the release of proangiogenic factors, such as vascular endothelial growth factor, β-nerve growth factor and neuropeptides. Proangiogenic factors might also stimulate nerve growth, and molecules produced by vascular cells could both stimulate and guide nerve growth. As sensory nerves grow along new blood vessels in osteoarthritic joints, they eventually penetrate noncalcified articular cartilage, osteophytes and the inner regions of menisci. Angiogenesis could, therefore, contribute to structural damage and pain in OA and provide potential targets for new treatments.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1996 Oct 1;184(4):1519-24 - PubMed
    1. J Biol Chem. 2007 Oct 19;282(42):30485-96 - PubMed
    1. Osteoarthritis Cartilage. 2010 Apr;18(4):593-600 - PubMed
    1. Arthritis Rheum. 2006 Nov;54(11):3494-507 - PubMed
    1. Lancet. 1989 Feb 11;1(8633):289-93 - PubMed

MeSH terms